Top compounds associated with response to BRK1


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.8
mRNA thalidomide CTRPv2 pan-cancer AAC 0.016 0.8
mRNA masitinib GDSC1000 pan-cancer AAC 0.01 0.8
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC 0.012 0.8
mRNA 968 CTRPv2 pan-cancer AAC 0.021 0.8
mRNA Zebularine CTRPv2 pan-cancer AAC 0.01 0.8
mRNA Axitinib GDSC1000 pan-cancer AAC -0.011 0.8
Download CSV